Breast CancerYogaQuality of LifeNursingEndocrine Therapy
Investigational drug(s) / intervention(s)
Yoga (intervention) group
Yoga (intervention) group: The yoga (intervention) group comprises 34 women with breast cancer who have been randomly assigned and are undergoing endocrine therapy. To alleviate arthralgia and vasomotor symptoms (hot flashes, night sweats), a structured yoga program will be administered during the initial months of endocrine therapy, consisting of 70-minute sessions, 4 days per week, for a duration of one month.
Study summary
The goal of this randomized controlled trial is to evaluate the effect of a yoga program on improving the quality of life, reducing joint pain, and alleviating vasomotor symptoms (night sweats, hot flashes) in women with breast cancer undergoing endocrine therapy.
The main questions it aims to answer are:
Does the yoga program significantly improve the quality of life in women with breast cancer undergoing endocrine therapy? Is the yoga program effective in reducing joint pain in women with breast cancer? Does the yoga program reduce the severity of night sweats and hot flashes in women with breast cancer? Researchers will compare the intervention group, which will receive the yoga program, to the control group, which will continue with their physician-recommended routine exercise, to see if there is a difference in these outcomes.
Participants will: Participants will consist of women with breast cancer undergoing endocrine therapy, with 34 in the yoga (intervention) group and 34 in the control group.
Complete the;Patient Assessment Form; and the Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES) scale.
The intervention group will participate in a 70-minute yoga program, delivered online via a digital platform, four days a week for six weeks, led by an instructor.
The control group will not receive any intervention and will continue with their physician-recommended routine exercise.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Being over 18 years of age,
* Having the ability to read, write, and speak Turkish,
* Having a diagnosis of breast cancer,
* Having completed surgical treatment,
* Having completed chemotherapy or radiation therapy,
* Recently starting endocrine therapy,
* Having a Body Mass Index (BMI) below 35.
Exclusion Criteria:
* Being over 70 years of age,
* Having a diagnosis of metastatic disease,
* Previous participation in yoga or similar exercises,
* Having a physical disability that prevents practicing yoga,
* Having a condition that causes shortness of breath (e.g., COPD),
* Having another chronic heart or lung disease that prevents yoga practice,
* Having a serious psychiatric illness or cognitive impairment.
Primary outcome measure(s)
Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES) — 1 week before the participants start the Yoga program. Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES): This comprehensive scale was developed to evaluate the quality of life of cancer patients, particularly those receiving endocrine therapy. The scale consists of 46 items rated on a scale from 0 to 4, and it includes five primary subscales: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Endocrine Symptom Subscale. Subscale scores are calculated separately, and the total score is the sum of the subscale scores. Higher scores indicate better quality of life and fewer symptoms. It is valid for cancer patients aged 18 and over, assessing experiences over the past seven days. The assessment uses a 5-point Likert scale and takes approximately 10-15 minutes.
Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES) — through study completion, average of one year Functional Assessment of Cancer Therapy - Endocrine Symptoms (FACT-ES): This comprehensive scale was developed to evaluate the quality of life of cancer patients, particularly those receiving endocrine therapy. The scale consists of 46 items rated on a scale from 0 to 4, and it includes five primary subscales: Physical Well-Being, Social/Family Well-Being, Emotional Well-Being, Functional Well-Being, Endocrine Symptom Subscale. Subscale scores are calculated separately, and the total score is the sum of the subscale scores. Higher scores indicate better quality of life and fewer symptoms. It is valid for cancer patients aged 18 and over, assessing experiences over the past seven days. The assessment uses a 5-point Likert scale and takes approximately 10-15 minutes.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.